Carl M. Sellgren

5.2k total citations · 1 hit paper
81 papers, 3.4k citations indexed

About

Carl M. Sellgren is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Genetics. According to data from OpenAlex, Carl M. Sellgren has authored 81 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Psychiatry and Mental health, 35 papers in Biological Psychiatry and 11 papers in Genetics. Recurrent topics in Carl M. Sellgren's work include Bipolar Disorder and Treatment (43 papers), Tryptophan and brain disorders (35 papers) and Schizophrenia research and treatment (22 papers). Carl M. Sellgren is often cited by papers focused on Bipolar Disorder and Treatment (43 papers), Tryptophan and brain disorders (35 papers) and Schizophrenia research and treatment (22 papers). Carl M. Sellgren collaborates with scholars based in Sweden, United States and United Kingdom. Carl M. Sellgren's co-authors include Mikael Landén, Carl Johan Ekman, Sophie Erhardt, Erik Pålsson, Roy H. Perlis, Steven D. Sheridan, Joel Jakobsson, Jessica Gracias, Göran Engberg and Ting Fu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Carl M. Sellgren

76 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning

2019 504 citations Carl M. Sellgren, Jessica M. Thanos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl M. Sellgren Sweden	34	1.5k	1.4k	611	603	594	81	3.4k
Tomasz Gos Poland	27	1.3k 0.9×	526 0.4×	736 1.2×	593 1.0×	588 1.0×	91	2.9k
Hendrik Bielau Germany	25	1.5k 1.0×	653 0.5×	889 1.5×	869 1.4×	852 1.4×	47	3.4k
Matthias Rothermundt Germany	42	1.7k 1.2×	908 0.6×	998 1.6×	751 1.2×	1.7k 2.9×	89	4.6k
Kotaro Hattori Japan	32	1.3k 0.9×	653 0.5×	633 1.0×	351 0.6×	1.3k 2.2×	157	4.0k
Toshiya Teraishi Japan	29	965 0.7×	588 0.4×	525 0.9×	233 0.4×	775 1.3×	96	2.8k
Ralf Brisch Germany	20	1.3k 0.9×	496 0.4×	783 1.3×	716 1.2×	643 1.1×	41	2.6k
Gabriela Delevati Colpo United States	27	783 0.5×	851 0.6×	242 0.4×	276 0.5×	531 0.9×	66	2.4k
Dunja Hinze‐Selch Germany	32	1.0k 0.7×	862 0.6×	611 1.0×	261 0.4×	389 0.7×	66	3.4k
Souhel Najjar United States	21	646 0.4×	661 0.5×	261 0.4×	621 1.0×	511 0.9×	37	2.5k
Janine Doorduin Netherlands	24	1.1k 0.7×	437 0.3×	616 1.0×	1.0k 1.7×	590 1.0×	92	3.1k

Countries citing papers authored by Carl M. Sellgren

Since Specialization

Citations

This map shows the geographic impact of Carl M. Sellgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl M. Sellgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl M. Sellgren more than expected).

Fields of papers citing papers by Carl M. Sellgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl M. Sellgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl M. Sellgren. The network helps show where Carl M. Sellgren may publish in the future.

Co-authorship network of co-authors of Carl M. Sellgren

This figure shows the co-authorship network connecting the top 25 collaborators of Carl M. Sellgren. A scholar is included among the top collaborators of Carl M. Sellgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl M. Sellgren. Carl M. Sellgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orhan, Funda, Neda Khanlarkhani, Marja Koskuvi, et al.. (2025). Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia. American Journal of Psychiatry. 182(4). 389–400.

Koskuvi, Marja, Sohvi Ohtonen, Eszter Molnár, et al.. (2025). Human oligodendrocyte progenitor cells mediate synapse elimination through TAM receptor activation. Nature Communications. 16(1). 10612–10612.

Sellgren, Carl M., et al.. (2025). Rare Copy Number Variants Reveal Critical Cell Types and Periods of Brain Development in Neurodevelopmental Disorders. Biological Psychiatry Global Open Science. 5(4). 100495–100495. 1 indexed citations

Koskuvi, Marja, Anniella Isgren, Helena Fatouros‐Bergman, et al.. (2024). Lower complement C1q levels in first-episode psychosis and in schizophrenia. Brain Behavior and Immunity. 117. 313–319. 2 indexed citations

Cernvall, Martin, Jacqueline Borg, Pontus Plavén‐Sigray, et al.. (2024). Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode Psychosis. JAMA Psychiatry. 81(5). 468–468. 26 indexed citations

Ho, Ada Man‐Choi, Vinod K. Gupta, Surendra Dasari, et al.. (2024). Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis. Journal of Psychiatric Research. 171. 306–315. 2 indexed citations

Edén, Arvid, Janet L. Cunningham, Jonas Bergquist, et al.. (2024). Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses. Brain Behavior and Immunity. 124. 163–176. 3 indexed citations

Engberg, Göran, Fredrik Piehl, Simon Červenka, et al.. (2023). Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis. Psychiatry and Clinical Neurosciences. 77(12). 665–671. 7 indexed citations

Isgren, Anniella, Jessica Holmén‐Larsson, Carl M. Sellgren, et al.. (2022). Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Molecular Psychiatry. 27(11). 4568–4574. 11 indexed citations

10.

Sheridan, Steven D., Jessica M. Thanos, Rose M. De Guzman, et al.. (2021). Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure. Translational Psychiatry. 11(1). 179–179. 17 indexed citations

11.

Sellgren, Carl M., Helena Fatouros‐Bergman, Fredrik Piehl, et al.. (2020). CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects. IBRO Reports. 8. 136–142. 6 indexed citations

12.

Lundberg, Martin, Vincent Millischer, Lena Backlund, et al.. (2020). Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder. Frontiers in Psychiatry. 11. 586083–586083. 21 indexed citations

13.

Pålsson, Erik, Carl M. Sellgren, Eleonore Rydén, et al.. (2017). Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls. Journal of Neural Transmission. 124(9). 1135–1143. 20 indexed citations

14.

Isgren, Anniella, Carl M. Sellgren, Jessica Holmén‐Larsson, et al.. (2017). Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes. Brain Behavior and Immunity. 65. 195–201. 71 indexed citations

15.

Schwieler, Lilly, Martin Samuelsson, Mark A. Frye, et al.. (2016). Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. Journal of Neuroinflammation. 13(1). 51–51. 84 indexed citations

16.

Pavlová, Barbara, Roy H. Perlis, Outi Mantere, et al.. (2016). Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis. Psychological Medicine. 47(6). 1107–1115. 36 indexed citations

17.

Rolstad, Sindre, Erik Pålsson, Carl Johan Ekman, et al.. (2015). Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder. Bipolar Disorders. 17(8). 859–868. 19 indexed citations

18.

Sparding, Timea, Erik Pålsson, Carl M. Sellgren, et al.. (2015). Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and II. PLoS ONE. 10(1). e0115562–e0115562. 39 indexed citations

19.

Rolstad, Sindre, Joel Jakobsson, Carl M. Sellgren, et al.. (2015). CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment. European Neuropsychopharmacology. 25(8). 1091–1098. 44 indexed citations

20.

Sellgren, Carl M., Mikael Landén, Paul Lichtenstein, Christina M. Hultman, & Niklas Långström. (2011). Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatrica Scandinavica. 124(6). 447–453. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact